ALK and non-small cell lung carcinoma: <h4>Background</h4>Epidermal growth factor receptor (EGFR) mutations and anaplastic lymphoma kinase (ALK) rearrangements are typically considered mutually exclusive in non-small cell lung cancer (NSCLC).